Steuerung des GKV-Arzneimittelmarktes – Auswirkungen von Selbstbeteiligungen und Härtefallregelungen
This analysis shows that hardship and not hardship cases respectively reject clear differences both at the demand and at the expenditures for pharmaceuticals financed by the statutory health insurance. Hardship cases without exemption regulations would be burden therefore by enormous co-payments. Moreover, it also turns out that straight hardship cases are less healthy on average than not hardship cases. Co-payments without accompanying hardship case regulations would therefore hardly make a supply possible adapted to the needs of hardship cases. On the other hand the effectivity of drug co-payment regulations is reduced by hardship case regulations considerably.
|Date of creation:||Jun 2006|
|Date of revision:|
|Contact details of provider:|| Postal: Universitaetsstrasse 16, D-86159 Augsburg, Germany|
Phone: +49 821 598 4060
Fax: +49 821 598 4217
Web page: http://www.wiwi.uni-augsburg.de/vwl/institut
More information through EDIRC
When requesting a correction, please mention this item's handle: RePEc:aug:augsbe:0285. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Dr. Albrecht Bossert)
If references are entirely missing, you can add them using this form.